Related Experiment Video
Updated: May 1, 2026
Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
Metastasis models: the green fluorescent revolution?
Sébastien Paris1, Richard Sesboüé
1Laboratory of Biochemistry and Cellular Biology, University of Namur, 61 Rue de Bruxelles, 5000 Namur, Belgium. sebastien.paris@fundp.ac.be
Abstract:
Metastases are the leading cause of treatment failure and death of patients affected by malignant tumors, which makes them a major therapeutic target. During the last decade, efforts made to understand the mechanisms governing the passage of a localized tumor cell to a metastatic one has led to significant advances in this field. In vivo models using nude mice largely contributed to the understanding of this multi-step phenomenon, thus allowing the discovery of new targets and the development of therapeutic agents. These models were however hampered by the difficulties to detect micrometastases. The recent introduction of the green fluorescent protein (GFP) as a marker for tumor cells has radically changed the use of these models, in particular by allowing detection of single cell metastases in vivo. In this review, we discuss the major advantages of models using GFP-labeled cells and their limits.
Insights
Green fluorescent protein (GFP) labeling revolutionized in vivo cancer metastasis research by enabling detection of single-cell spread. This advance significantly aids in understanding tumor progression and developing new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Metastasis is the primary cause of cancer-related death, making it a critical therapeutic target.
- Understanding the multi-step process of tumor cell metastasis has advanced significantly.
- Traditional in vivo models faced challenges in detecting early-stage micrometastases.
Purpose of the Study:
- To review the advantages and limitations of using green fluorescent protein (GFP)-labeled cells in metastasis research.
- To highlight how GFP technology has improved the study of tumor cell dissemination in vivo.
- To discuss the impact of GFP labeling on the discovery of new therapeutic targets for metastatic cancer.
Main Methods:
- Utilizing in vivo models, specifically nude mice, to study tumor metastasis.
- Employing green fluorescent protein (GFP) as a cellular marker for tracking tumor cells.
- Analyzing the detection capabilities of GFP-labeled cells for micrometastases.
Main Results:
- GFP labeling allows for the in vivo detection of single tumor cells, overcoming previous limitations in micrometastasis detection.
- GFP-labeled models have greatly enhanced the understanding of metastasis mechanisms.
- The use of GFP has facilitated the identification of novel therapeutic targets and agents.
Conclusions:
- GFP-labeled cells represent a significant advancement in in vivo metastasis research.
- These models offer unprecedented insights into tumor cell dissemination and metastatic progression.
- Further research utilizing GFP technology holds promise for developing more effective cancer therapies.
More Related Videos
Related Concept Videos
02:11Reporter Genes
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...